AstraZeneca Dividend 2018, yield and historyTweet
AstraZeneca was established in 1999 and has its head office in Cambridge, England. It is a pharmaceutical company. It was founded when the Astra AB company from Sweden and the English Zeneca company merged together. After the merger, the company has become stronger than ever and has acquired a position among the world’s largest pharmaceutical companies. A drug manufactured by AstraZeneca called Iressa was approved in Japan in 2002 for the treatment of non-small cell lung cancer. It announced in February 2018 that it was introducing six early-stage experimental drugs into Viela Bio, which was a new biotechnological company.